Login to Your Account



Clinic Roundup


Thursday, August 30, 2012
• Collegium Pharmaceutical Inc., of Cumberland, R.I., said it started enrollment in a Phase III study of Oxycodone DETERx (COL-003), a tamper-resistant, extended-release version of oxycodone.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription